EUVIMEDEUVIMED entdecken
Crossref

Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis

Meican Ma, Ting Liu, Haifeng Chen, Zhao Wang, Jie Zhou, Yu Zhou, Fenghong Yuan

Archives of Medical Research · 2026

DOI: 10.1016/j.arcmed.2025.103283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Medical Research, 2026. Verfasst von Meican Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, C…. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Arthritis, Rheumatoid, Muscle Proteins, Synovial Membrane. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Wuxi Municipal Bureau on Science and Technology, Nanjing Medical University, Wuxi Science and Technology Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In hypoxic conditions, the acidic environment characteristic of rheumatoid arthritis (RA) induces metabolic changes in fibroblast-like synoviocytes (FLS), markedly promoting the synovial proliferation. Monocarboxylate transporter 4 (MCT4) plays a crucial role in cellular pH regulation and synovial fibroblast activation by regulating lactate export. This study investigates the impact of MCT4 inhibition on RA and elucidates its underlying mechanisms. METHOD: RA-FLS cells were treated with siMCT4 and VB124 (a selective MCT4 inhibitor), significantly affecting glucose and glutamine uptake and altering lactate efflux. Metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) revealed the mechanisms of carbon metabolism reprogramming. ChIP-qPCR analysis demonstrated changes in hypoxia-inducible factor-1α (HIF1-α) binding to the MCT4 promoter. The therapeutic effects of siMCT4 and VB124 were validated in a collagen-induced arthritis (CIA) model, and their efficacy was assessed through arthritis scores and histological examination. RESULTS: In patients with RA, MCT4 levels are significantly elevated. Inhibition of MCT4 effectively reduces synovial hyperproliferation and impacts metabolic reprogramming. Specifically, blocking MCT4 in RA-FLS reduces glucose consumption and lactate production while remodeling the metabolic landscape by increasing fumarate, citrate, and malate levels, and decreasing glucose-6-phosphate and aspartate levels. This metabolic shift is accompanied by improvements in mitochondrial structure and function, reduced mitochondrial swelling, and decreased oxidative stress, underscoring the relationship between MCT4 inhibition and cellular energetics. Furthermore, our investigations reveal that HIF1-α directly regulates MCT4 activation, providing a molecular mechanism by which hypoxia promotes MCT4-mediated metabolic reprogramming. CONCLUSION: These findings highlight MCT4 as a central regulator of RA proliferation and a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monocarboxylic Acid TransportersArthritis, RheumatoidMuscle ProteinsSynovial MembraneHumansAnimalsCell ProliferationSynoviocytesMaleMiceHypoxia-Inducible Factor 1, alpha SubunitArthritis, ExperimentalFemaleCells, CulturedCell HypoxiaMetabolic Reprogramming

Stichwörter der Autor:innen

Carbon metabolismFibroblast-like synoviocyteHypoxiaMonocarboxylate transporter 4Rheumatoid arthritis

Substanzen

Monocarboxylic Acid TransportersSLC16A4 protein, humanMuscle ProteinsHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. Electronic address: Yfh222222@163.com.

Förderung

  • Wuxi Municipal Bureau on Science and Technology
  • Nanjing Medical University
  • Wuxi Science and Technology Association

Zitieren

APA

Ma, M., Liu, T., Chen, H., Wang, Z., Zhou, J., Zhou, Y., & Yuan, F. (2026). Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis. Archives of Medical Research. https://doi.org/10.1016/j.arcmed.2025.103283

Vancouver

Ma M, Liu T, Chen H, Wang Z, Zhou J, Zhou Y, et al. Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis. Archives of Medical Research. 2026. doi:10.1016/j.arcmed.2025.103283

BibTeX
@article{Ma2026,
  author = {Ma, Meican and Liu, Ting and Chen, Haifeng and Wang, Zhao and Zhou, Jie and Zhou, Yu and Yuan, Fenghong},
  title = {Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis},
  journal = {Archives of Medical Research},
  year = {2026},
  doi = {10.1016/j.arcmed.2025.103283}
}
Kostenlos starten →